Massive valproic acid overdose, a misleading case

American Journal of Emergency Medicine

Volumn 26, Issue 1, 2008, Pages 110.e3-110.e6

  Sikma, Maaike ^a   Mier, J C ^a   Meulenbelt, J ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; BENZODIAZEPINE; CARBON DIOXIDE; CARNITINE; NORADRENALIN; OPIATE; PARACETAMOL; PROPOFOL; VALPROIC ACID;

ADULT; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BRAIN CYST; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSULTATION; DISEASE SEVERITY; DRUG BLOOD LEVEL; DRUG INTOXICATION; DRUG OVERDOSE; DRUG WITHDRAWAL; EPILEPSY; EPILEPTIC STATE; GLIOSIS; HUMAN; HYPOTENSION; HYPOTHERMIA; INTENSIVE CARE UNIT; KIDNEY DYSFUNCTION; LABORATORY TEST; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RHABDOMYOLYSIS; SEIZURE;

EID: 36849073173     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.06.020     Document Type: Article

References (16)

1. Isbister G.K., Balit C.R., Whyte I.M., et al. Valproate overdose: a comparative cohort study of self poisonings. Br J Clin Pharmacol 55 (2003) 398-404
2. Chadwick D.W., Cumming W.J., and Livingstone I. Acute intoxication with sodium valproate. Ann Neurol 6 6 (1979) 552-553
3. El Desoky E.U., Mahmoud R.K., Abdel-Halim M.A., et al. Spotlight on the continual applicability of routine plasma monitoring antiepileptic drugs in the treatment of epilepsy. Pharmacol Res 39 4 (1999) 269-274
4. Spiller H.A., Krenzelok P., Klein-Schwartz W., et al. Multicenter case series of valproic acid ingestion: serum concentrations and toxicity. J Toxicol Clin Toxicol 38 7 (2000) 755-760
5. Eyer F., Felgenhauer N., Gempel K., et al. Acute valproate poisoning, pharmacokinetics, alteration in fatty acid metabolism, and changes during therapy. J Clin Psychopharmacol 25 4 (2005) 376-380
6. Buechler R.D., and Buchhalter J.R. Juvenile absence epilepsy exacerbated by valproic acid. Pediatr Neurol 36 (2007) 121-124
7. Sztajnkrycer M.D. Valproic acid toxicity: overview and management. J Toxicol Clin Toxicol 40 6 (2002) 789-801
8. Cotariu D., and Zaldman J.L. Valproic acid and the liver. Clin Chem 34 5 (1988) 890-897
9. Singh S.M., McCormick B.B., Mustata S., et al. Extracorporeal management of valproic acid overdose: a large regional experience. J Nephrol 17 (2004) 43-49
10. Vale J.A., Krenzelok E.P., and Barceloux G.D. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 37 6 (1999) 731-751
11. Kane S.L., Constantiner M., Staubus A.E., et al. High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose. Ann Pharmacother 34 (2000) 1146-1151
12. Prietsch V., Lindner M., Zschocke J., et al. Emergency management of inherited metabolic diseases. J Inherit Metab Dis 25 (2002) 531-546
13. Meek M.F., Broekroelofs J., Yska J.P., et al. Valproic acid intoxication: sense and non-sense of haemodialysis. Neth J Med 62 9 (2004) 333-336
14. Graeme K., Higgins T., Curry S., et al. Markedly elevated valproate levels do not serve as an indication for hemodialysis or hemoperfusion. J Toxicol Clin Toxicol 37 5 (1999) 636
15. Farrar H.C., Herold D.A., and Reed M.D. Acute valproic acid intoxication: enhanced drug clearance with oral-activated charcoal. Crit Care Med 21 (1993) 299-301
16. Raskind J.Y., and El-Chaar G.M. The role of Carnitine supplementation during valproic acid therapy. Ann Pharmacother 34 (2000) 630-638